Tubular ischemia and toxicity

Conclusions: EPC-derived EVs protect the kidney from ischemic AKI by delivering mRNAs coding for factor H, DAF and CD59 to injured tubular epithelial and endothelial cells. These results confirmed previous data on the relevance of complement inhibition after kidney IRI and suggest the potential use of EPC-derived EVs as therapeutic option to avoid delayed graft function after kidney transplantation.

Source: Nephrology Dialysis Transplantation - May 10, 2013 Category: Urology & Nephrology Authors: Cantaluppi, V., Medica, D., Figliolini, F., Gatti, S., Bruno, S., Quercia, A. D., Dellepiane, S., Biancone, L., Tetta, C., Camussi, G., Zhou, L., Dai, X., Feng, M., Huang, X., Fu, P., Lan, H. Y., de Ramon, L., Ripoll, E., Luzardo, L., Merino, A., Bolanos, Tags: Abstracts Source Type: research